Synapse - Find an Expert

33620 Results

The effect of current smoking on mortality in cancer patients

Meeting Abstract

Warren, G. W.; Alberg, A.; Cummings, K. M.; Dresler, C. M.; Hanna, N. H.; Ostroff, J. S.; Marshall, J. R.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Pretreatment neutrophil to lymphocyte ratio as an independent predictor of disease-specific survival in resectable GE junction and gastric adenocarcinoma

Meeting Abstract

Wang, S. C.; Chou, J. F.; Strong, V. E.; Brennan, M. F.; Capanu, M.; Coit, D. G.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Identification and validation of predictive biomarkers (BM) for everolimus (EVE) in metastatic renal cell carcinoma: Analysis of 442 patients on RECORD-3

Meeting Abstract

Voss, M. H.; Chen, D.; Marker, M.; Hamilton, M.; Kalfoglou, C.; Hsieh, J.; Knox, J. J.; Anak, O.; Motzer, R. J.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

First-in-human phase I "basket" study of Debio1347 (CH5183284), a novel FGFR inhibitor, in patients FGFR genoinically activated advanced solid tumors

Meeting Abstract

Voss, M. H.; Adamo, B.; Heist, R. S.; Gandhi, L.; Moulon, C.; Tanaka, H.; Ishii, N.; Vasiln, A.; Aoki, Y.; Nicolas-Metral, V.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Phase 2 feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate with or without prophylactic growth factor (GF) for adjuvant treatment of early-stage breast cancer (EBC)

Meeting Abstract

Traina, T. A.; Kaufman, P. A.; Cadoo, K. A.; Hudis, C. A.; Chang, C.; Berrak, E.; Song, J.; Cox, D.; Seidman, A. D.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer

Meeting Abstract

Traina, T. A.; O'Shaughnessy, J.; Kelly, C. M.; Schwartzberg, L. S.; Gucalp, A.; Peterson, A. C.; Tudor, I. C.; Blaney, M. E.; Steinberg, J. L.; Trudeau, M. E.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Establishing a neoadjuvant platform for developing targeted agents: Degarelix prior to prostatectomy for patients with intermediate- and high-risk prostate cancer

Meeting Abstract

Touijer, K. A.; Carver, B. S.; Coleman, J. A.; Laudone, V. P.; Hullings, M.; Ehrlich, S. S.; DeNunzio, M.; Reuter, V. E.; Eastham, J. A.; Danila, D. C.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A phase 2 trial of minocydine versus placebo to prevent neuropathy in patients (pts) with multiple myeloma (MM)

Meeting Abstract

Thomas, S. K.; Mendoza, T. R.; Dougherty, P. M.; Williams, L. A.; Wang, X. S.; Prasad, S.; Shah, N.; Shah, J. J.; Wang, M.; Weber, D. M.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A randomized phase II trial of bevacizumab (BV) plus oral everolimus (EV) versus bevacizumab alone for recurrent or persistent epithelial ovarian (EOC), fallopian tube (FTC), or primary peritoneal cancer (PPC)

Meeting Abstract

Tew, W. P.; Sill, M.; McMeekin, D. S.; Secord, A. A.; Bonebrake, A. J.; Schilder, J.; Stuckey, A.; Rice, L.; Tewari, K. S.; Aghajanian, C.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

APACT: A phase 3 randomized, open-label, multicenter trial evaluating the use of adjuvant nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with surgically resected ductal pancreatic adenocarcinoma (PDA)

Meeting Abstract

Tempero, M. A.; Cardin, D. B.; Biankin, A.; Goldstein, D.; Moore, M.; O'Reilly, E. M.; Philip, P. A.; Riess, H.; Macarulla, T.; Yung, L.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

33620 Results

People

Groups

Results (33620)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract